Anthropic introduces 10b5-1 plan: regulating employee stock sale mechanism ahead of planned IPO
While preparing for its IPO, Anthropic introduced rare risk controls for employee stock sales: amid rapid expansion with about 5,300 employees and a target valuation of $1.4 trillion, it mandates a 10b5-1 trading plan usually limited to executives, to avoid insider trading compliance risks heightened by increased information flow after listing. Teresa Greenip, a director at Aspiriant, revealed that the mechanism allows executives and employees to sell shares according to preset rules.